Pediatrics

A large cohort study offers important data on what factors are frequently tied to severe cases of COVID-19 in the pediatric population.

PCOS prevalence in girls with type 2 diabetes was almost 20%.

The days of blanket mitigation strategies to protect children from COVID-19 are becoming a thing of the past. One model sheds light onto determining when strategies can be relaxed.

Evidence suggests some pharmaceutical excipients in medications may have adverse effects on pediatric patients. Here’s what you should know.

Abigail Donovan, MD, discusses what brexpiprazole can do for treating schizophrenia in older children.

Emerging evidence is changing health care providers’ approach to treating pediatric rheumatic diseases.

This past year has seen several important new drug approvals and labeling updates for children. Here is what you should know.

Pharmacists can help at-risk youth with asthma through the CAReS program, providing school-based asthma care.

Surviving a bout of cancer early in life puts children and teenagers at risk of cancers linked to human papillomavirus (HPV). A phase 2 trial examined how effective a 3-dose series was in providing protection.

Not every vaccine is required, some are just strongly recommended. Here's what to know about 5 recommended vaccines.

During a session at the 2021 American Academy of Pediatrics National Conference & Exhibition research revealed that introduction to common allergy foods early on can be key in decreasing the frequency of development in children.

Ocugen, Inc. has submitted a request to the FDA for emergency use authorization (EUA) of their COVID-19 vaccine candidate for use in children aged 2 to 18 years.

Initial results from the trial indicate it was well-tolerated and promoted a good immune response.

A press briefing from the Infectious Diseases Society of America focused on the concerns raised by the delta variant and its potential impact on schools.

To protect children and staff at schools, the Infectious Diseases Society of America (IDSA) has recommended using multiple science-based approaches to prevent spread in schools.

Ser/dex is a dexmethylphenidate-based prodrug for ADHD in patients 6 years and older.

For children who have either experienced a delay in pertussis vaccination or who haven’t received the recommended number of doses, what is their risk of pertussis? A new study provides answers.

At the virtual Scientific Sessions for the American Diabetes Association, Jennifer Sherr, MD, discussed the findings of a study of the Omnipod 5 automated insulin delivery system in very young children with type 1 diabetes.

There was a marked decline in child and adolescent routine vaccine administration during the COVID-19 pandemic between March and September 2020; these vaccination rates have continued to lag behind.

Viloxazine is a selective norepinephrine reuptake inhibitor and is the first new nonstimulant medication for treatment of ADHD in children in more than 10 years.

The FDA approved Cosentyx (secukinumab) to treat moderate-to-severe plaque psoriasis in children aged 6 years and older.

The company has publicized data from the TeenCOVE study of the vaccine along with plans to seek authorization in the coming weeks.

The Practice Advisory, developed by the American College of Obstetricians and Gynecologists (ACOG), offers an overview of the latest guidance for COVID-19 vaccination in pregnant and lactating patients.

The FDA has expanded the emergency use authorization for the COVID-19 vaccine to include individuals 12 to 15 years of age.

The approval marks the first novel non-stimulant treatment for ADHD.